glp-1 eating disorders #504: Adult in the Era Implications of GLP-1 medications for
Description
A new class action lawsuit alleges Hims & Hers falsely advertises its compounded GLP-1 semaglutide products as being the same as the weight loss and diabetes drugs Ozempic and Wegovy.
Dizziness during semaglutide treatment often stems from rapid blood sugar drops, dehydration, or dose escalation
Insurance coverage for Wegovy remains limited despite growing demand for GLP-1 weight loss therapy
Best results after 3 months of consistent, daily use
This has raised concerns about their impact on cancer risk, spurring extensive research
Energy, metabolism, cognitive function & vitality
